|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date16 Oct 1981 |
Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
泽泻降脂胶囊在中国健康人体内餐后单次给药的药代动力学试验。
[Translation] Pharmacokinetic study of Alisma Jiangzhi Capsules administered in a single postprandial dose in Chinese healthy subjects.
探索进食对泽泻降脂胶囊在中国健康人体内药动学过程的影响,同时观察安全性,为临床给药方案提供进一步依据。
[Translation] To explore the effect of food intake on the pharmacokinetic process of Alisma Jiangzhi Capsules in Chinese healthy subjects, and to observe the safety at the same time, so as to provide further basis for clinical dosing regimen.
泽泻降脂胶囊在中国健康人体内连续给药的耐受性和药代动力学试验
[Translation] Tolerance and pharmacokinetics of Alisma Jiangzhi Capsules administered continuously in Chinese healthy subjects
探索连续给药在中国健康受试者的耐受性、药动学特征及体内蓄积情况,为Ⅱ期临床试验给药方案提供依据。
[Translation] To explore the tolerance, pharmacokinetic characteristics and accumulation in the body of continuous administration in Chinese healthy subjects, so as to provide the basis for the dosage regimen of phase II clinical trials.
泽泻降脂胶囊在中国健康人体内空腹单次给药的耐受性和药代动力学试验。
[Translation] Tolerability and pharmacokinetics of Alisma japonicum capsules in Chinese healthy subjects with a single dose on an empty stomach.
探索研究药物在中国健康受试者的安全耐受剂量、观察药物的不良事件/反应,分析单次给药的药代动力学特征。
[Translation] To explore the safe and tolerated dose of the study drug in healthy Chinese subjects, observe the adverse events/reactions of the drug, and analyze the pharmacokinetic characteristics of a single dose.
100 Clinical Results associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co Ltd
0 Patents (Medical) associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co Ltd
100 Deals associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co Ltd
100 Translational Medicine associated with Shanghai Xiandai Medicine Preparation Engineering Research Centre Co Ltd